NCT01651585View on ClinicalTrials.gov

In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

July 31, 2015

Conditions
Foetuses InfectionCytomegalovirus (CMV)Infection
Interventions
DRUG

Valacyclovir arrow

dosage form:500mg, dosage:8g/day, frequency: 4 a day duration: 23 weeks maximum

Trial Locations (1)

75015

Hospital Necker Enfants Malades, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01651585 - In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir | Biotech Hunter | Biotech Hunter